Zydus Cadila gets tentative approval from USFDA for cancer drug

Shares of Cadila Healthcare, the listed entity of the group closed at Rs 531.35 per scrip on BSE, down 0.10 percent from its previous close.

Shares of Cadila Healthcare, the listed entity of the group closed at Rs 531.35 per scrip on BSE, down 0.10 percent from its previous close. https://ift.tt/37Pa2xf August 17, 2021 at 01:22AM

Comments

Popular posts from this blog

US may impose tariffs on India, Italy for taxing internet firms like Google

No locus standi: India rejects US global religious freedom report